CVS Health (CVS) closed at $79.12 in the latest trading session, marking a +1.38% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.32%. Meanwhile, the ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS Health’s (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits ...

CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the ...

CVS Health ( ($CVS) ) has provided an update. On December 9, 2025, CVS Health held its 2025 Investor Day, where it updated its financial guidance ...

So you are wondering whether CVS Health at around $77.79 is still a smart buy after its big run, or if you are showing up late to the party, this breakdown will help you separate real value from just ...

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read here for more analysis.

Discover why CVS Health Corporation is a top S&P 500 performer in 2025. See bullish forecasts, strong growth, and a new price target. Click for this CVS update.

On Thursday, the Centers for Medicare & Medicaid Services (“CMS”) released the 2026 Star Ratings for Medicare Advantage Prescription Drug (“MAPD”) plans. The five-star rating system evaluates Medicare ...